N-(2-Meth-oxy-benz-yl)-9-(oxolan-2-yl)-9H-purin-6-amine
Status PubMed-not-MEDLINE Jazyk angličtina Země Spojené státy americké Médium electronic-print
Typ dokumentu časopisecké články
PubMed
23634119
PubMed Central
PMC3629632
DOI
10.1107/s1600536813007721
PII: ng5319
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
The title compound, C17H19N5O2, features an almost planar purine skeleton (r.m.s. deviation = 0.009 Å) substituted by a tetra-hydro-furan ring, which adopts an envelope conformation. The purine and benzene rings subtend a dihedral angle of 66.70 (3)°. In the crystal, pairs of N-H⋯N hydrogen bonds connect adjacent mol-ecules into inversion dimers. C-H⋯N, C-H⋯O, C-H⋯π and π-π inter-actions [pyrimidine ring centroid-centroid distance = 3.3909 (1) Å] connect the dimers into a three-dimensional architecture.
Zobrazit více v PubMed
Agilent (2012). CrysAlis PRO Agilent Technologies Ltd, Yarnton, England.
Brandenburg, K. (2011). DIAMOND Crystal Impact GbR, Bonn, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. PubMed
Štarha, P., Popa, I., Dvořák, Z. & Trávníček, Z. (2013). Acta Cryst. E69, o533. PubMed PMC
Szüčová, L., Spíchal, L., Doležal, K., Zatloukal, M., Greplová, J., Galuszka, P., Kryštof, V., Voller, J., Popa, I., Massino, F. J., Jørgensen, J. E. & Strnad, M. (2009). Bioorg. Med. Chem. 17, 1938–1947. PubMed
Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.